Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Boehringer Ingelheim
US Department of Justice
Federal Trade Commission

Generated: November 21, 2017

DrugPatentWatch Database Preview

Claims for Patent: 4,642,346

« Back to Dashboard

Claims for Patent: 4,642,346

Title: Anhydrous crystalline 9-(1,3-dihydroxy-2-propoxymethyl)guanine
Abstract:Novel anhydrous crystalline 9-(1,3-dihydroxy-2-propoxymethyl)guanine useful as an antiviral agent.
Inventor(s): Chan; Tai W. (Palo Alto, CA), Nguyen; Huong T. (Saratoga, CA)
Assignee: Syntex (U.S.A.) Inc. (Palo Alto, CA)
Application Number:06/747,631
Patent Claims: 1. Anhydrous crystalline 9-(1,3-dihydroxy-2-propoxymethyl)guanine.

2. The anhydrous crystals of claim 1 further characterized by water of hydration of less than 1% w/w.

3. The anhydrous crystals of claim 2 further characterized by m.p. 243.degree. C.-245.degree. C.

4. The anhydrous crystals of claim 3 characterized by the powder X-ray diffraction pattern shown in FIGS. IA, IB or IC.

5. The process for preparing the anhydrous crystals of claim 1 which comprises

(i) adding 9-(1,3-dihydroxy-2-propoxymethyl)guanine to a heated oxygen-containing solvent;

(ii) cooling the mixxture formed in step (i) to room temperature; and

(iii) recovering the crystals formed in step (ii).

6. The process of claim 5 wherein the oxygen-containing solvent is dimethyl acetamide or water.

7. The process of claim 6 wherein the solvent is warmed to 60.degree. to 100.degree. C.

8. The process of claim 7 which further comprises adding methanol or acetone to the warm solution.

9. The process of claim 5 wherein the oxygen-containing solvent is an alcohol of one to four carbon atoms.

10. The process of claim 9 wherein the solvent is warmed to 40.degree. to 80.degree. C.

11. A process for preparing the anhydrous crystals of claim 1 which comprises heating a suitable form of 9-(1,3-dihydroxy-2-propoxymethyl)guanine.

12. The process of claim 11 wherein the suitable form is 9-(1,3-dihydroxy-2-propoxymethyl)guanine hydrate.

13. The process of claim 12 wherein the hydrate is heated to 200.degree.-220.degree. C.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus